A61P 5/12
For decreasing, blocking or antagonising the activity of the posterior pituitary hormones
Official title: for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
A61P5/12 (For decreasing, blocking or antagonising the activity of the posterior pituitary hormones) appears on 153 US grants and 135 published applications in this corpus.
Search patents in A61P- Granted patents
- 153
- Published applications
- 135
- Assignees
- 96
- Inventors
- 392
- Latest grant
- 10 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 4 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 8 | 0 |
| 1997 | 7 | 0 |
| 1998 | 9 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 7 | 1 |
| 2002 | 5 | 8 |
| 2003 | 6 | 13 |
| 2004 | 8 | 15 |
| 2005 | 5 | 4 |
| 2006 | 2 | 7 |
| 2007 | 3 | 7 |
| 2008 | 4 | 14 |
| 2009 | 3 | 8 |
| 2010 | 3 | 8 |
| 2011 | 2 | 6 |
| 2012 | 9 | 8 |
| 2013 | 6 | 1 |
| 2014 | 5 | 3 |
| 2015 | 5 | 4 |
| 2016 | 4 | 3 |
| 2017 | 1 | 4 |
| 2018 | 0 | 1 |
| 2019 | 2 | 2 |
| 2020 | 2 | 5 |
| 2021 | 1 | 5 |
| 2022 | 1 | 1 |
| 2023 | 1 | 3 |
| 2024 | 1 | 2 |
| 2025 | 0 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Spiro-oxazolones10 Dec 2024US 12,162,887 B2Hoffmann-La Roche Inc.
- Spiro-oxazolones14 Feb 2023US 11,578,077 B2Hoffmann-La Roche Inc.
- Amine substituted triazole derivatives and uses thereof17 May 2022US 11,331,314 B2Bayer Pharma Aktiengesellschaft
- Pharmaceutical solid preparation comprising benzazepines and production method thereof2 Feb 2021US 10,905,694 B2Otsuka Pharmaceutical Co., Ltd.
- Triazole derivatives and their use as PDE4 activators6 Oct 2020US 10,793,531 B2Mironid Limited
- Controlled release formulations of octreotide14 Aug 2025US 2025/0255936 A1Endo Operations Limited
- Spiro-oxazolones27 Feb 2025US 2025/0066378 A1Hoffmann-La Roche Inc.
- Compositions and methods for the treatment of addiction and other neuropsychiatric disorders1 Feb 2024US 2024/0033258 A1Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Compositions and methods for the treatment or prevention of preterm labor25 Jan 2024US 2024/0024294 A1Xoma (US) LLC
- Pharmaceutical solid preparation comprising benzazepines and production method thereof12 Oct 2023US 2023/0321113 A1Otsuka Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Dispersible antibody compositions and methods for their preparation and use351US 6,019,968 AInhale Therapeutic Systems · 2000
- Spray drying of macromolecules to produce inhaleable dry powders220US 6,582,728 B1Inhale Therapeutic Systems · 2003
- Human growth hormone variants153US 5,849,535 AGenentech, Inc. · 1998
- Methods of spray-drying a drug and a hydrophobic amino acid123US 6,372,258 B1Inhale Therapeutic Systems · 2002
- Stable glassy state powder formulations102US 6,258,341 B1Inhale Therapeutic Systems · 2001